Botulinum Toxin in Neurogenic Detrusor Overactivity

Botulinum Toxin in Neurogenic Detrusor Overactivity

Purpose To evaluate the effects of botulinum toxin on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity. Methods Thirty four adult patients with spinal cord injury and detrusor overactivity were selected. The patients received 300 units of botulinum toxin ty...

Full description

Bibliographic Details
Main Authors:	Carlos Arturo Levi D'Ancona, Rúiter Silva Ferreira, Mauricio Carneiro Rassi
Format:	Article
Language:	English
Published:	Korean Continence Society 2012-09-01
Series:	International Neurourology Journal
Subjects:	Overactive urinary bladder Botulinum toxins Quality of life Urodynamics
Online Access:	http://www.einj.org/upload/pdf/inj-16-3-139-8.pdf

Similar Items

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
by: Yu-Hua Fan, et al.
Published: (2023-03-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Idiopathic and neurogenic detrusor overactivity: do the different patterns have urodynamic characteristics related to gender or neurological condition?
by: Francoise A. Valentini, et al.
Published: (2013-09-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships
by: Françoise A. Valentini, et al.
Published: (2011-12-01)

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Perioperative Techniques for the Use of Botulinum Toxin in Overactive Bladder: Results of a Multinational Online Survey of Urogynecologists in Germany, Austria, and Switzerland
by: Sören Lange, et al.
Published: (2023-02-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
by: Chung-Cheng Wang, et al.
Published: (2020-03-01)

Impact of overactive bladder on retrograde ejaculation
by: Ahmet Salvarci, et al.

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
by: Naoki Wada, et al.
Published: (2022-09-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia
by: Yu-Hui Huang, et al.
Published: (2022-03-01)

Children with Non-Neurogenic Lower Urinary Tract Dysfunction Require Less Frequent and Number of Botulinum Toxin Injections Than Neurogenic Ones
by: Kamranbay Gasimov, et al.
Published: (2022-12-01)

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes
by: Yin-Chien Ou, et al.
Published: (2023-01-01)

Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors
by: Jefferson Kalil, et al.
Published: (2020-03-01)

Urethral pressure variation: a neglected contributing factor in patients with overactive bladder syndrome?
by: Ruth Kirschner-Hermanns, et al.

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
by: Heinrich Schulte-Baukloh, et al.
Published: (2022-12-01)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
by: Sheng-Fu Chen, et al.
Published: (2022-01-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
by: Hsiang-Ying Lee, et al.
Published: (2023-03-01)